www.worldpharmatoday.com monthly e-Newsletter is meticulous compilation of vital contemporary aspects of Pharma industry. This e-Newsletter presents the latest updates on the Technotrends, Research insights, Case studies, Pharma projects and analysis from industry experts, Articles which are relevant for Pharma Professionals to keep them informed of the latest industry updates.
News | Upcoming Events | Press Releases | Research Insight | Industry Report | Techno Trends
Upcoming Events
eyeforPharma Barcelona 2016
15.03.2016 - 17.03.2016
Centre Convencions Internacional Barcelona Plaça de Willy Brandt, 11-14 08019 Barcelona
W: http://www.eyeforpharma.com/barcelona/

CPhI/ ICSE/ P-MEC/ BioPh/ InnoPack Japan 2016
20.04.2016 - 22.04.2016
Tokyo Big Sight Exhibition Center
W: http://www.cphi.com/japan/home

7th Annual Global Drug Delivery & Formulation Summit
23.05.2016 - 25.05.2016
Maritime proArte Hotel Berlin, Germany
W: http://www.ddfevent.com

CPhI, ICSE & P-MEC China 2016
01.06.2016 - 03.06.2016
Istanbul Congress Center, Istanbul, Turkey
W: http://www.cphi-istanbul.com

INTERPHEX JAPAN 2016 - 29th INT'L PHARMACEUTICAL R&D AND MANUFACTURING EXPO/CONFERENCE
29.06.2016 - 01.07.2016
Tokyo, JAPAN
W:
http://www.interphex.jp/en/

in-PHARMA JAPAN 2016 - 10th INT'L PHARMACEUTICAL INGREDIENTS EXPO & CONFERENCE
29.06.2016 - 01.07.2016
Tokyo, JAPAN
W:http://www.pijapan.jp/en/

Industry Report
Innate pharma in-licenses orega biotech's first-in-class anti-cd39 checkpoint inhibitor program
Innate Pharma and OREGA Biotech today announce that they have entered into an exclusive licensing agreement by which OREGA Biotech grants Innate Pharma full worldwide rights to its program of first-in-class anti-CD39 checkpoint inhibitors.
Advertise your content
Advertise in Our Next Issue
.
Contact
Mr. Sunny Rogers
Product Manager
T: +91 8447612124
E: sunny@worldpharmatoday.com
(or)
Press Releases
Nutrition and health bars expand market share by tying into wellness, athleticism
Read more...
Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval
Read more...
U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance® (Empagliflozin)
Read more...
Lilly And Roche Diagnostics To Collaborate On Alzheimer's Disease
Read more...
News
Lilly and Incyte Announce Submission of New Drug Application to FDA
Read more...
FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
Read more...
Novartis receives two new FDA approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis in the US
Read more...
Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool
Read more...
Research Insight
AstraZeneca partners with peers and academia to establish translational research fund
Read more...
SINE^tm Technology
Read more...
AstraZeneca and Incyte announce new lung cancer clinical trial collaboration
Read more...

Technology Update
Novartis Access....
Read more...



.

Copyright @ 2016 World Pharma Today